pyridoxal has been researched along with Diabetic Neuropathies in 3 studies
Diabetic Neuropathies: Peripheral, autonomic, and cranial nerve disorders that are associated with DIABETES MELLITUS. These conditions usually result from diabetic microvascular injury involving small blood vessels that supply nerves (VASA NERVORUM). Relatively common conditions which may be associated with diabetic neuropathy include third nerve palsy (see OCULOMOTOR NERVE DISEASES); MONONEUROPATHY; mononeuropathy multiplex; diabetic amyotrophy; a painful POLYNEUROPATHY; autonomic neuropathy; and thoracoabdominal neuropathy. (From Adams et al., Principles of Neurology, 6th ed, p1325)
| Excerpt | Relevance | Reference |
|---|---|---|
| "We examined the ability of a pyridoxal-aminoguanidine adduct with both antiglycation and antioxidant activities in vitro to protect against neuropathy and cataract in streptozotocin-diabetic rats and compared the result with that of aminoguanidine." | 7.72 | Pyridoxal-aminoguanidine adduct is more effective than aminoguanidine in preventing neuropathy and cataract in diabetic rats. ( Chen, AS; Kamei, A; Miwa, I; Sugiura, M; Taguchi, T; Wakasugi, Y; Wang, MW, 2004) |
| "Serum pyridoxal concentrations were estimated in 13 patients who had both diabetes and carpal tunnel syndrome." | 7.66 | Carpal tunnel syndrome, diabetes and pyridoxal. ( Davis, RE; McCann, VJ, 1978) |
| "We examined the ability of a pyridoxal-aminoguanidine adduct with both antiglycation and antioxidant activities in vitro to protect against neuropathy and cataract in streptozotocin-diabetic rats and compared the result with that of aminoguanidine." | 3.72 | Pyridoxal-aminoguanidine adduct is more effective than aminoguanidine in preventing neuropathy and cataract in diabetic rats. ( Chen, AS; Kamei, A; Miwa, I; Sugiura, M; Taguchi, T; Wakasugi, Y; Wang, MW, 2004) |
| "Serum pyridoxal concentrations were estimated in 13 patients who had both diabetes and carpal tunnel syndrome." | 3.66 | Carpal tunnel syndrome, diabetes and pyridoxal. ( Davis, RE; McCann, VJ, 1978) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, AS | 1 |
| Taguchi, T | 1 |
| Sugiura, M | 1 |
| Wakasugi, Y | 1 |
| Kamei, A | 1 |
| Wang, MW | 1 |
| Miwa, I | 1 |
| McCann, VJ | 2 |
| Davis, RE | 2 |
3 other studies available for pyridoxal and Diabetic Neuropathies
| Article | Year |
|---|---|
Pyridoxal-aminoguanidine adduct is more effective than aminoguanidine in preventing neuropathy and cataract in diabetic rats.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; Cataract; Deoxyguanosine; Diabetes Mellitus, Experimental; Dia | 2004 |
Serum pyridoxal concentrations in patients with diabetic neuropathy.
Topics: Adolescent; Adult; Aged; Autonomic Nervous System; Diabetes Mellitus; Diabetic Neuropathies; Female; | 1978 |
Carpal tunnel syndrome, diabetes and pyridoxal.
Topics: Adult; Aged; Carpal Tunnel Syndrome; Diabetes Complications; Diabetes Mellitus; Diabetic Neuropathie | 1978 |